https://www.selleckchem.com/products/sb273005.html
Despite a considerable increase in the list of TBK1 inhibitors, only a few has potential to control cancer. Among them, a compound BX795 is considered a potent and selective inhibitor of TBK1. We discussed the therapeutic potential of small-molecule inhibitors of TBK1, particularly those with high selectivity, which will enable further exploration in the therapeutic management of cancer and inflammatory diseases.A cellulose nanocrystal based oxidation system is developed for oxidizing starch in the presence of NaClO, and provides an al
Curtir
Comentario
Compartilhar
